About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Austin | 112 Studies

Clinical Trials Prostate CancerAustin

Prostate Cancer Clinical Trials in Austin

Find 112 clinical trials for prostate cancer near Austin, Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Austin

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 112 trials

RecruitingA Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate CancerThe primary objective of this study is to compare overall survival (OS) in participants receiving xaluritamig plus abiraterone against investigator's choice (docetaxel…NCT07213674·Goodyear, Arizona and 155 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Registry of Sipuleucel-T Therapy in Men With Advanced Prostate CancerThe purpose of this study is to further quantify the risk of cerebrovascular events (CVEs) following sipuleucel-T (PROVENGE®) therapy, and to follow all subjects for survival.NCT01306890·Bessemer, Alabama and 332 others

Active not recruitingEnzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate CancerThis phase 2 randomised clinical trial will investigate the activity and safety of adding Lu-PSMA to enzalutamide in patients with metastatic castrate resistant prostate cancer…NCT04419402·Camperdown, New South Wales and 14 others

Active not recruitingSafety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)The purpose of this study is to assess enzalutamide plus leuprolide in patients with high-risk nonmetastatic prostate cancer progressing after radical prostatectomy or…NCT02319837·Birmingham, Alabama and 254 others

TerminatedA Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.A first-in-human clinical trial to test the investigational treatment ONCT-534 in participants with metastatic castration-resistant prostate cancer.NCT05917470·San Francisco, California and 9 others

CompletedComparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate CancerThis Phase 3 study has been designed to confirm that adding custirsen to cabazitaxel/prednisone treatment can slow tumor progression and enhance survival outcomes compared to…NCT01578655·Marina del Rey, California and 93 others

Approved for marketingStudy of Abiraterone Acetate in Patients With Advanced Prostate CancerThe purpose of this study is to collect additional safety information on abiraterone acetate administered with prednisone to patients with metastatic castration-resistant prostate…NCT01217697·Birmingham, Alabama and 296 others

CompletedPROFIT - Prostate Fractionated Irradiation TrialThis trial is designed to determine whether an 8-week course of escalated dose conformal radiation can be compressed safely, and with similar efficacy into a 4-week course.NCT00304759·Liverpool, New South Wales and 24 others

UnknownASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing TaxotereThe purposes of this study are to determine if DN-101 plus Taxotere lowers PSA levels, delays or limits disease progression and is safe with minimal side effects.NCT00043576·Montgomery, Alabama and 61 others

CompletedProstate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)The purpose of this study is to determine if toremifene citrate is effective and safe in the prevention of prostate cancer in men who have been diagnosed with high grade prostatic…NCT00106691·Huntsville, Alabama and 137 others

CompletedA Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate CancerThe purpose of this study is to evaluate the prevalence of 4 or more DNA-repair gene defects in a population of men with metastatic Prostate Cancer (PC) and to use the reported…NCT03871816·Homewood, Alabama and 337 others

CompletedStudy of XB002 in Subjects With Solid Tumors (JEWEL-101)This is a Phase 1, open-label, multicenter, dose-escalation and expansion study evaluating the safety, tolerability, PK, pharmacodynamics, and clinical antitumor activity of XB002…NCT04925284·Birmingham, Alabama and 94 others

RecruitingA Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate CancerThis study will test whether BNT324 is safe and works better against metastatic castration-resistant prostate cancer (mCRPC) than the current standard of care (SoC) chemotherapy…NCT07365995·Santa Barbara, California and 32 others

TerminatedMGC018 With or Without MGA012 in Advanced Solid TumorsThe purpose of this study is to evaluate the safety and tolerability, pharmacokinetics (PK) pharmacodynamics and preliminary antitumor activity of vobramitamab duocarmazine…NCT03729596·Santa Monica, California and 20 others

Active not recruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple…NCT02465060·Birmingham, Alabama and 1409 others

Not yet recruitingWATER IV PCa (AS Sub-study)The WATER IV study is a multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate…NCT07650448·Chandler, Arizona and 24 others

CompletedAssessment of New Radiation Oncology Technologies and TreatmentsThe Trans Tasman Radiation Oncology Group (TROG) has been commissioned by the Department of Health and Ageing to undertake a project to assess new Radiation Oncology Technology…NCT01379872·Camperdown, New South Wales and 14 others

RecruitingA Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid TumorsIDE574 is a synthetically manufactured small molecule inhibitor that co-targets the lysine acetyltransferase enzymes KAT6 and KAT7.NCT07540572·Plantation, Florida and 10 others

CompletedPrevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)Less than 20% of men in whom prostate cancer is diagnosed early die from it. Cardiovascular disease is the most common cause of death in men with early prostate cancer.NCT01006395·Heidelberg, Victoria

Active not recruitingAn Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)The purpose of this study is to compare the radiographic progression-free survival (rPFS) of apalutamide in combination with abiraterone acetate (AA) plus prednisone or…NCT02257736·Phoenix, Arizona and 172 others

Page 1 of 6Next

Other Conditions in Austin

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma